These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9075111)

  • 1. Nonsteroidal anti-inflammatory drugs (NSAIDs) and the kidney.
    Pugliese F; Cinotti GA
    Nephrol Dial Transplant; 1997 Mar; 12(3):386-8. PubMed ID: 9075111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of COX-2-selective inhibitors.
    Brater DC; Harris C; Redfern JS; Gertz BJ
    Am J Nephrol; 2001; 21(1):1-15. PubMed ID: 11275626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Case report: reversible acute renal failure following therapy with both ketorolac (non-selective non-steroidal anti-inflammatory drug NSAID) and celecoxib (COX-2 selective) in the same patient].
    Galli G; Panzetta G
    G Ital Nefrol; 2002; 19(2):199-203. PubMed ID: 12195419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COX-2 and the kidneys.
    Stichtenoth DO; Frölich JC
    Curr Pharm Des; 2000 Nov; 6(17):1737-53. PubMed ID: 11102561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dual acting anti-inflammatory drugs: a reappraisal.
    Bertolini A; Ottani A; Sandrini M
    Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemistry of prostaglandin endoperoxide H synthase-1 and synthase-2 and their differential susceptibility to nonsteroidal anti-inflammatory drugs.
    Smith WL; DeWitt DL
    Semin Nephrol; 1995 May; 15(3):179-94. PubMed ID: 7631045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective inhibitors of type 2 cyclooxygenase: less renal effects than the classical non-steroidal anti-inflammatory agents].
    Chiolero A; Würzner G; Burnier M
    Nephrologie; 2000; 21(8):425-30. PubMed ID: 11213386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase 1 and 2 in rheumatic disease: implications for nonsteroidal anti-inflammatory drug therapy.
    Spangler RS
    Semin Arthritis Rheum; 1996 Aug; 26(1):435-46. PubMed ID: 8870111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclo-oxygenase-2 inhibitors and the kidney: a case for caution.
    Noroian G; Clive D
    Drug Saf; 2002; 25(3):165-72. PubMed ID: 11945113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonsteroidal anti-inflammatory drugs and heart failure.
    Bleumink GS; Feenstra J; Sturkenboom MC; Stricker BH
    Drugs; 2003; 63(6):525-34. PubMed ID: 12656651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. COX2 selective NSAIDs and renal function: gain without pain?
    Breyer MD
    Kidney Int; 1999 Feb; 55(2):738-9. PubMed ID: 9987099
    [No Abstract]   [Full Text] [Related]  

  • 12. Differential inhibition of murine prostaglandin synthase-1 and -2 by nonsteroidal anti-inflammatory drugs using exogenous and endogenous sources of arachidonic acid.
    Chulada PC; Langenbach R
    J Pharmacol Exp Ther; 1997 Feb; 280(2):606-13. PubMed ID: 9023270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of NSAIDs on prostaglandin synthesis].
    Watanabe T; Higuchi K; Tominaga K; Uchida T; Fujiwara Y; Arakawa T
    Nihon Rinsho; 2002 Feb; 60 Suppl 2():190-4. PubMed ID: 11979776
    [No Abstract]   [Full Text] [Related]  

  • 14. New NSAIDs--inhibitors of cyclooxygenase 2--and renal damage.
    Navarro JF; Mora C; García J
    Br J Rheumatol; 1996 Dec; 35(12):1332. PubMed ID: 9010074
    [No Abstract]   [Full Text] [Related]  

  • 15. [Prostaglandin/bradykinin].
    Hirawa N; Umemura S
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():183-8. PubMed ID: 15250292
    [No Abstract]   [Full Text] [Related]  

  • 16. The discovery and function of COX-2.
    Needleman P; Isakson PC
    J Rheumatol Suppl; 1997 Jul; 49():6-8. PubMed ID: 9249644
    [No Abstract]   [Full Text] [Related]  

  • 17. [Physiopathological and therapeutic study of collagen diseases based on results of clinical tests--role of prostaglandins].
    Sano H
    Nihon Naika Gakkai Zasshi; 1998 Dec; 87(12):2438-45. PubMed ID: 9922664
    [No Abstract]   [Full Text] [Related]  

  • 18. Do non-steroidal anti-inflammatory drugs and COX-2 selective inhibitors have different renal effects?
    Giovanni G; Giovanni P
    J Nephrol; 2002; 15(5):480-8. PubMed ID: 12455713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New directions in cyclooxygenase research and their implications for NSAID-gastropathy.
    Flower RJ
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():23-7. PubMed ID: 9032578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
    Moran EM
    J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.